---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-23-050518"
form_type: "8-K/A"
ticker: "BMY"
cik: "0000014272"
company_name: "BRISTOL MYERS SQUIBB CO"
filed_at: "2023-10-31T23:59:59+00:00"
generated_at: "2026-06-09T04:28:55.311639+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Bristol-Myers details CEO succession; Caforio to retire April 1, 2024, Boerner Chairman

## Summary
- Giovanni Caforio steps down as CEO, becomes Executive Chairman Nov 1, 2023, then retires from Board April 1, 2024.
- Christopher Boerner appointed CEO effective Nov 1, 2023; will also become Chairman on April 1, 2024.
- Boerner's new package: $1.5M base salary, 150% target bonus, additional $1.6M LTI (60% PSUs, 40% MSUs).
- Caforio's salary and bonus unchanged during transition; no further LTI awards after March 2024.
- Board size set at 11 effective April 1, 2024, following Caforio's retirement.

## SEC filing metadata
- accession: 0001140361-23-050518
- form_type: 8-K/A
- ticker: BMY
- cik: 0000014272
- company_name: BRISTOL MYERS SQUIBB CO
- filed_at: 2023-10-31T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/14272/000114036123050518/0001140361-23-050518-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/14272/000114036123050518/ef20013739_8ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-23-050518
- JSON: https://secwatch.observer/filing/0001140361-23-050518.json
- Plain text: https://secwatch.observer/filing/0001140361-23-050518.txt

## Key facts
- Executive change
  Giovanni Caforio departed as Director at BRISTOL MYERS SQUIBB CO.
  - Action: retire
  - Role: Director
  source text: On October 25, 2023, Dr. Caforio advised the Board that he will not stand for re-election to the Board at the 2024 Annual Meeting of Shareholders, and will retire from the Board, effective April 1, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/14272/000114036123050518/0001140361-23-050518-index.htm
- Executive change
  Christopher Boerner was appointed as Chief Executive Officer at BRISTOL MYERS SQUIBB CO.
  - Action: appointed
  - Role: Chief Executive Officer
  source text: appointment of Christopher Boerner, Ph.D. as Chief Executive Officer by the Board, effective November 1, 2023
  evidence_url: https://www.sec.gov/Archives/edgar/data/14272/000114036123050518/0001140361-23-050518-index.htm
- Executive change
  Christopher Boerner was appointed as Chairman of the Board at BRISTOL MYERS SQUIBB CO.
  - Action: appointed
  - Role: Chairman of the Board
  source text: the Board approved the appointment of Dr. Boerner as Chairman of the Board in addition to Chief Executive Officer, effective April 1, 2024
  evidence_url: https://www.sec.gov/Archives/edgar/data/14272/000114036123050518/0001140361-23-050518-index.htm
- Executive change
  Giovanni Caforio was appointed as Executive Chairman at BRISTOL MYERS SQUIBB CO.
  - Action: appointed
  - Role: Executive Chairman
  source text: retirement of Giovanni Caforio, M.D. as Chief Executive Officer and his election as Executive Chairman of the Board of Directors of the Company (the “Board”), effective November 1, 2023
  evidence_url: https://www.sec.gov/Archives/edgar/data/14272/000114036123050518/0001140361-23-050518-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.